High Cost of Healthcare in the United States-A Manifestation of Corporate Greed
Pankaj Mathur*, Shweta Srivastava and Jawahar L Mehta
Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA
- *Corresponding Author:
- Mathur P
Department of Internal Medicine
Slot 816 , UAMS Medical Center
Little Rock, AR 72205, USA
E-mail: [email protected]
Received date: October 19, 2015; Accepted date: December 22, 2015; Published date: December 29, 2015
Citation: Mathur P, Srivastava S, Mehta JL (2015) High Cost of Healthcare in the United States-A Manifestation of Corporate Greed. J Forensic Med 1:103. doi:10.4172/2472-1026.1000103
Copyright: © 2015 Mathur P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Rising costs of health care has been a cause of concern in recent years. According to the latest estimates we spend $2.9 trillion dollars every year, around 18% of the GDP, and about $9,255 per person each year in health care costs. But it is highly debatable if this high expenditure translates into improved patient care and healthcare outcomes. The healthcare is presently considered an industry or a business venture. The corporatization of medicine leading to the rising administrative costs and growing cost of prescription drugs and devices is also a cause of concern and are major contributing factors to the rising health care costs. The practice of defensive medicine is, in part, contributing to the present situation. We believe that the present-fee-for-service reimbursement model needs to be changed to value-based-care which can help in improvement of patient care outcomes without increase in the health care costs. Major health care reforms are long overdue, but who will ring the cat?